QuickView for BRCA1;jsessionid=0AEB3A596880D09A80763A00AC617159;jsessionid=C17DFF21FB6A7D320DCF2C6CAF05E5F0;jsessionid=934DE44E59485DE9F71A4660B4279172;jsessionid=C2B437E91935810C1DA74900BE7D6549 (gene)

1. BRCA1 deficiency in triple-negative breast cancer: Protein stability as a basis for therapy.
2. Association of common BRCA1 variants with predisposition to breast tumors in Pakistan.
3. BRCA1 protects against its own fragility.
4. BRCA1: An Endocrine and Metabolic Regulator.
5. Bractoppin, a BRCA1 carboxy-terminal domain (BRCT) inhibitor, suppresses tumor progression in ovaria…

There were no clinical trials for BRCA1;jsessionid=0AEB3A596880D09A80763A00AC617159;jsessionid=C17DFF21FB6A7D320DCF2C6CAF05E5F0;jsessionid=934DE44E59485DE9F71A4660B4279172;jsessionid=C2B437E91935810C1DA74900BE7D6549